2007/2008 lung health funding/clinical trials

2007/2008 Lung Health Funding/Clinical Trials
RESEARCHER AMOUNT
A double-blind, randomized, placebo-controlled, multicenter study to assess the efficacy, safety and tolerability of bosentan in patients with idiopathic Protocol AC-052-321 BUILD 3: Effects of Bosentan on Morbidity and Mortality in Patients With Idiopathic Pulmonary Fibrosis - A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel Group, Clinical Trial Event-Driven, Group Sequential, Phase Protocol D5892C00015 (CLIMB): a 12-week, double-blind, randomised, parallel group, multi-centre study to evaluate efficacy and safety of budesonide/ formoterol (symbicort(r) turbuhaler(r)) 320/9 ug one inhalation Clinical Trial twice daily on top of tiot Protocol 1222.6 (Project Nickname BI 1744 CL): Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy (Bronchodilation) and Safety of 4 Weeks of Once Daily Treatment of Orally Inhaled BI 1744 CL (2up, 205.372-Spiriva Respimat(TM) Study: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess Long Term (one-year) Efficacy and Safety of Tiotropium Inhalation Solution 5ug (2 puffs of Clinical Trial 2.5ug) Delivered by the Respimat IICT: Asthma in Obese Subjects - Diagnostic & $15,300.00 Health Research (CIHR) Clinical Trial Therapeutic Strategies SA: Development and Cellular Mechanisms involved in the Pathological Changes to the epithelium in A phase 3,multicentre,randomized,placebo-controlled,double-blind,three-arm study to evaluate the safety and efficacy of Tifacogin(recombinant tissue factor pathway inhibitor) administration in subjects Clinical Trial with sever community-acquired pneumon A Phase 3, Double-Blind, Multicenter, Multinational, Randomized, Placebo-Controlled Trial Evaluating Aztreonam Lysinate for Inhalation in Cystic Fibrosis Clinical Trial Patients with P. Aeruginosa (AIR-CF1) Clinical Trial Choline Nutrition in Children with Cystic Fibrosis UBC Vancouver Hospital Respiratory Faculty 2007/2008 Lung Health Funding/Clinical Trials
RESEARCHER AMOUNT
Protocol FPH03 STRIDE III: Long-Term Open-Label Study to Evaluate the Safety of Sitaxsentan Sodium Treatment in Patients with Pulmonary Arterial SCO100250: A Randomized, Double-Blind, Parallel Group, 52-week Study to Compare the Effect of the Fluticasone Propionate/Salmeterol DISKUS Combination Product 250/50mcg BID with Salmeterol Protocol AIM (ADC105931): A Randomized, Double-Blind, Parallel-Group, 14-Week Study to Evaluate the Anti-Inflammatory Effect of Fluticasone Propionate/ Salmeterol DISKUS 250/50mcg BID Compared to Clinical Trial Salmeterol DISKUS 50mcg BID in Subjects With A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Three-Arm Study of the Safety and Efficacy of Pirfenidone in Patients with Idiopathic Pulmonary A randomized, double-blind, placebo-controlled phase II study of the safety and efficacy of subcutaneous recombinant interferon-y1b (rlFN-y 1b) in patients with Clinical Trial idiopathic pulmonary fibrosis A randomized,double-blind,placebo-controlled,phase 3 study of the safety and efficacy of Interferon Gamma-1b in patients with idiopathic pulmonary fibrosis.(The INSPIRE Trial: INternational study of Clinical Trial Survival outcomes in IPF with InteRfEron Protocols LVGX and LVGY: A Randomized Double-Blind, Study to Evaluate the Long-Term Safety and Efficacy of the Phosphodiesterase Type 5 (PDE5) Inhibitor Tadalafil in the Treatment of Patients with Clinical Trial Pulmonary Arterial Hypertension IICT: A Phase III Randomized Study of Exemestane vs. Placebo in Postmenopausal Women at Increased Clinical Trial Risk of Developing Breast Cancer IICT: Diesel Exhaust and Atherosclerotic Plaque Spectral Imaging of Early Lung Cancers and Pre- DPM-CF-202:A Phase 2A,Randomised,Open Label,Dose Response Study to Determine the Optimum Dose of Dry Powder Mannitol Required to Generate Clinical Improvement in Patients with Cystic Clinical Trial Role of Telemedicine in the Initiation of Nasal CPAP The role of (R) and (S) enantomers of albuterol in Clinical Trial mucosal injury and repair in pediatric asthma 2007/2008 Lung Health Funding/Clinical Trials
RESEARCHER AMOUNT
CPR-0003: Study to Find Out If a New Medical Device Called the Intra-Bronchial Valve (IBV) is Safe and Clinical Trial Effective to Use in Subjects With Severe Emphysema IICT: Can Advair and Flovent reduce systemic inflammation related to COPD? A multi-center Clinical Trial randomized controlled Trial. protocol topigen asthma study: a phase ii, randomized, double-blind, placebo-controlled, parallel-groups, multicenter study to evaluate and compare the safety, tolerability and efficacy of two dosaGES OF Clinical Trial INHALED TPI ASM8 (0.25 MG AND 0.5

Source: http://www.centreforlunghealth.ca/uploads/files/clinicaltrials.pdf